Tell us what are you looking for
As we want to personally help you, please let us know what type of information you are interested in.
This action will now change your filtered view.
colorectal cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added Feb 25, 2021
Does aspirin help survival rates in colorectal cancer?
This study investigated the association between the use of aspirin after the diagnosis for colorectal cancer (CRC) and CRC-specific survival and overall survival. Researchers suggested that the use of aspirin after diagnosis is associated with a positive outcome.
colorectal cancer | Research | 10 pages | source: PLOS ONE | Added Feb 23, 2021
A possible way to prevent oxaliplatin induced liver damage
This study investigated how oxaliplatin chemotherapy causes liver damage.
The authors provided insight into the mechanism of liver injury, and suggest that bevacizumab (Avastin) may protect against such injury.
colorectal cancer | Research | 12 pages | source: World journal of gastroenterology (WJG) | Added Feb 18, 2021
Monitoring colorectal cancer survivors: What’s done currently and what’s next?
This article reviewed the current views on how best to monitor colorectal cancer survivors in order to detect return of cancer locally or at new sites as early as possible.
colorectal cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Feb 16, 2021
Evaluating the use of radiotherapy followed by chemotherapy before surgery for locally-advanced rectal cancer.
This trial looked at the use of short-course radiotherapy (RT) followed by chemotherapy (CT) and delayed surgery to reduce distant metastases (tumor spread) in patients with locally advanced rectal cancer (LARC). The trial found that this treatment was more effective in controlling distant metastases when compared to standard chemoradiotherapy (CRT) followed by surgery and adjuvant CT (chemotherapy after surgery).
colorectal cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Feb 09, 2021
What is the optimal duration of chemotherapy after surgery for patients with stage III colon cancer?
This trial looked at the length of adjuvant chemotherapy (AC; chemotherapy after surgery) for patients with stage III colon cancer. The authors found that 3 months of AC resulted in similar survival with reduced levels of toxicity, and cost compared to 6 months.
colorectal cancer | Research | Lifestyle | 15 pages | source: Journal of clinical oncology | Added Feb 07, 2021
Can your diet really help you survive colorectal cancer?
This study examined the impact of higher calcium, vitamin D and dairy products on colorectal cancer survival.